We are a team of scientists with broad backgrounds ranging from molecular and chemical biology, genomics, epigenetics, and cell biology, to computational biology, statistical modeling, and machine learning, who are passionate about using our groundbreaking biological and computational technologies for enhancing human health and drug discovery.
Ronen has over 20 years of experience in academic research in the fields of genomics and epigenetics, protein homeostasis, cell biology, biochemistry, and molecular biology. He did his PhD at the Technion, Israel under the supervision of Nobel laureate Aaron Ciechanover.
Israa holds a PhD in Biochemistry and Molecular biology from the Hebrew University in Jerusalem. She then joined the Friedman lab as a postdoctoral researcher, where she extended the development of the cfChIP-seq assays and applied them to multiple medical questions.
Daniella brings over ten years of experience in pharmaceutical API global marketing at Teva Pharmaceuticals. She also brings strong operational background in biobanking and clinical trials as the founding manager of Israel's first and only population-based research biobank "TIPA" within Israel’s healthcare insurer/provider Maccabi Healthcare Services.
Prof. Galun is a full professor at the Hebrew University, and was until recently the Director of the Gene and Cell Therapy Institute, which he established in 1998 at Hadassah Hebrew University Hospital. Beyond his rich clinical career and academic record, Prof. Galun was founder of a company that developed monoclonal antibodies to treat hepatitis B and C patients.
Recipient of the 2006 Nobel Prize in Chemistry, Prof. Roger D. Kornberg serves as the Winzer Professor of Medicine in the Department of Structural Biology at Stanford University. Prof. Kornberg’s award winning research centered on the process by which DNA is converted into RNA. He also discovered the basic subunit of chromatin, the nucleosome and its relation to transcriptional regulation.